These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia. Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789 [TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia. Wyatt RJ; Murphy DL Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116 [No Abstract] [Full Text] [Related]
7. [Comparative characteristics of monoamine oxidases of the brain and thrombocytes]. Moskvitina TA Vestn Akad Med Nauk SSSR; 1991; (10):33-6. PubMed ID: 1801459 [No Abstract] [Full Text] [Related]
9. Average evoked response augmenting/reducing in schizophrenia and affective disorders. Buchsbaum M Res Publ Assoc Res Nerv Ment Dis; 1975; 54():129-42. PubMed ID: 769113 [No Abstract] [Full Text] [Related]
10. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls. Nies A; Robinson DS; Harris LS; Lamborn KR Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593 [No Abstract] [Full Text] [Related]
11. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia. Demisch L; von der Mühlen H; Bochnik HJ; Seiler N Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205 [TBL] [Abstract][Full Text] [Related]
12. Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. Murphy DL; Weiss R Am J Psychiatry; 1972 May; 128(11):1351-7. PubMed ID: 5020182 [No Abstract] [Full Text] [Related]
13. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups. Wise CD; Bridge TP; Potkin SG; Wyatt RJ Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348 [TBL] [Abstract][Full Text] [Related]
14. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
16. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853 [TBL] [Abstract][Full Text] [Related]
17. An 18-month followup of students biologically at risk for psychiatric problems. Haier RJ; Buchsbaum MS; Murphy DL Schizophr Bull; 1980; 6(2):334-7. PubMed ID: 7375866 [TBL] [Abstract][Full Text] [Related]
18. Platelet monoamine oxidase in affective illness and alcoholism. Belmaker RH; Bracha HS; Ebstein RP Schizophr Bull; 1980; 6(2):320-3. PubMed ID: 7375864 [TBL] [Abstract][Full Text] [Related]
19. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities. Murphy DL; Wyatt RJ Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115 [No Abstract] [Full Text] [Related]
20. Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues. Murphy DL; Donnelly CH Adv Biochem Psychopharmacol; 1974; 12(0):71-85. PubMed ID: 4607554 [No Abstract] [Full Text] [Related] [Next] [New Search]